Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research.

Whether you're culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have the specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. 

By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster.

Researchers in need of high-compliance products can also obtain guidance and customized support through our Services for Cell Therapy Program on how to qualify our products for use as raw/ancillary materials.

Visit Website



BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting. By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Visit Website

Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics – from discovery to delivery.

Together, as Cytiva, we supply the tools and support our customers need to work better, faster and safer, leading to the delivery of transformative medicines to patients.

Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit for more.

Visit Website

MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.

Visit Website

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy.

Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing.

Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training.

Today, Miltenyi Biotec has more than 4,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Visit Website

ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.

Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry.

Our platform includes GRex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.

Visit Website

Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results.

By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. 

Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis.

With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.

Visit Website

Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research.

Whether you're culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have the specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. 

By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster.

Researchers in need of high-compliance products can also obtain guidance and customized support through our Services for Cell Therapy Program on how to qualify our products for use as raw/ancillary materials.

Visit Website




Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. 

The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies.

The company's Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation.

Cell Shuttles will be deployed in Cellares' Smart Factories worldwide to meet total patient demand for cell therapies at global scale.

Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing."

Visit Website

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases.

We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence.

Our Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms as well as tools and technologies to enable you to develop, de-risk and industrialize your therapy, from basic research to commercialization.

Visit Website

OmniaBio Inc. is a dedicated cell and gene therapy contract development and manufacturing organization that provides comprehensive services to developers from early development through to commercial manufacturing.

As a CCRM subsidiary, OmniaBio builds on over a decade of expertise in regenerative medicine and advanced therapies, offering its clients extensive leadership in immune cell-based therapies, induced pluripotent stem cell-based therapies, and lentiviral vectors.

With current clinical manufacturing capabilities, and a commercial manufacturing facility opening this summer, OmniaBio is poised to meet the surging global manufacturing demand, enabling access to transformative treatments for patients around the world. 

Visit us at

Visit Website

Ori is a London and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies.

Ori has developed a proprietary, full- stack manufacturing platform that closes, automates and standardizes CGT manufacturing, allowing therapeutics developers to develop and bring their products to market at commercial scale.

The promise of the innovative Ori platform is to automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics.

Visit Website

PBS Biotech, Inc. offers unique single-use bioreactors and contract process development services for the global cell therapy market.

Our family of Vertical-Wheel bioreactors provides optimal and scalable hydrodynamic conditions for human cells including induced pluripotent stem cells, mesenchymal stem cells, T-cells, natural killer cells and other cell types.

Our Bioprocess R&D team possesses unparalleled knowledge regarding cell culture process development for a variety of cell types and applications.

PBS Biotech is committed to providing scalable solutions for all stages of cell therapy manufacturing, from R&D to clinical studies and ultimately commercial production.

Visit Website

Terumo Blood and Cell Technologies is a medical technology company.

Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions.

Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. 

Visit Website

As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development.

We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions.

Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing.

Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.

Visit Website

As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development.

We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions.

Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing.

Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.

Visit Website


908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications.

The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets.

The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

Visit Website

Since 2006, Akron’s mission has been to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies.

Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies.

Akron’s ancillary material product lines are ISO 13485-certified and its 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards.

Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through commercialization.

Visit Website

BCA centers generate >$3B in revenue annually managing >50% of the country’s supply of blood and blood components from >500 facilities owned by ~65 centers in 43 states supplying biomaterials from >3.5 million annual donors to thousands of hospitals.

BCA additionally represents access to 7 cord blood banks and 16 IRL testing facilities in 13 states. BCA itself manages >$1B in transactions generated through purchasing/selling contracts it has negotiated and manages on behalf of its members.

Specifically on the advanced therapies side, in 2021 BCA sites performed >10,000 cell therapy (autologous & healthy donor) collections + >20,000 therapeutic apheresis procedures on ~380 Optia devices at >50 locations. Many of these sites have or have already planned in the budget to incorporate or expand cryopreservation capabilities.

Visit Website

BioBridge Global, a San Antonio-based 501(c)(3) nonprofit, integrates donor-to-patient services to enable the future of biotherapeutic solutions, including blood, tissue and advanced therapies.

Through its subsidiaries – South Texas Blood & Tissue, QualTex Laboratories and GenCure – BioBridge Global provides products and services in blood resource management, cellular therapy manufacturing, donated umbilical cord blood and human tissue, as well as testing of blood, plasma, tissue and cellular products for clients in the United States and international markets. It supports the development of advanced therapies by providing access to starting materials, testing services, biomanufacturing and clinical trials support.

BioBridge Global is committed to saving and enhancing lives through the healing power of human cells and tissue.

Visit Website

BioCentriq is a global cell therapy Contract Development and Manufacturing Organization (CDMO) with a proven track record successfully transferring, developing, and manufacturing GMP drug product for use in clinical trials. The Executive, Technical, and Business Development teams have commercialized four unique cell therapies and translated more than 20 programs into the clinic.

This expertise, coupled with phase-appropriate quality systems and a modern infrastructure have established BioCentriq as a trusted strategic partner for the development and manufacture of autologous and allogeneic cell therapies. BioCentriq’s four flexible GMP manufacturing suites are supported by fully equipped process and analytical development laboratories to ensure seamless translation from the lab to the clinic.

In May 2022, BioCentriq was purchased by GC Holdings Inc. of South Korea for $73 million.
As an integral member of the GC global network, through teamwork and collaboration, BioCentriq and GC Cell offer harmonized CDMO services to facilitate seamless cross-border technology transfers to improve access to and reduce the cost of life-changing cell therapies. In June 2023, BioCentriq launched its LEAP™ Advanced Therapy Platform designed to help cell therapy developers move from contract to clinic in as little as six months.

Visit Website

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools and services.

Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® FRS shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, SciSafe® outsourced sample storage services, and Sexton Biotechnologies® cell processing and handling tools.

For more information, please visit and follow BioLife on LinkedIn and Twitter.

Visit Website

A global leader in in-vitro diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide.

The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.

At bioMérieux, we are proud to have a long history in the field of industrial microbiology. Cutting-edge cell and gene therapy products demand state-of-the-art quality control.

With a comprehensive portfolio of rapid microbiology testing solutions, bioMérieux can help streamline workflows, boost efficiency, prevent compliance issues and ensure patient safety.

Visit Website

Bio-ReCell is a cell therapy research and development company at the forefront of biomedical advancement.

Our team of seasoned experts in the field alongside young researchers, has led to the creation of the world's first closed and automated Bio-ReCell System, redefining cell separation and isolation standards within the industry.

Our revolutionary technology relies on a proprietary antibody-based approach, completely eliminating the need for magnetic particles. This innovation ensures that the resulting cell eluates are entirely devoid of contaminants, including residual antibodies, chemicals, and any other particles.

We maintain rigorous standards of sterility and bio compatibility, employing closed-loop cartridges tailored to specific cell types, which complete the isolation process in under 30 minutes. Scalability is a fundamental feature of our technology, accommodating the full spectrum of requirements, from single-patient applications to large-scale Good Manufacturing Practice (GMP) manufacturing processes.

Our versatile portfolio of cartridges targets various therapeutic objectives, primarily focusing on T-cells for advanced CAR-T therapies. Our product range includes also a system for cell activation, based on our proprietary technology. Bio-ReCell actively seeks strategic partnerships in both, commercial and research sectors, with a strong commitment to advancing cell and gene manufacturing and exploring novel clinical applications through collaborative clinical trials.

Visit Website

C3i Centre Inc is a CDMO that can take your technology from process development to commercial manufacturing without tech transferring to multiple sites.

C3i offers:

  • High production success rate of ~99% in over 300 clinical products
  • A team of rigorous and solution-driven scientists with a 15-year track record of cell therapy development and manufacturing experience.
  • Commercial manufacturing in 2024 in the EU, with Canada and US to follow.
  • Analytical testing including validated Qc tests.
  • CAP-accredited immune-monitoring and diagnostic testing services.
  • CRO services specializing in cell therapy clinical trials.
  • Partnership with a leading research hospital and access to KOLs.
  • A unique shared risk model by investing in innovative companies and offering in-kind services.

C3i’s vision is to make life-saving cell & gene therapies available to everyone who needs it. Our team truly understands that we are not just working with the patient’s cells but with a loved one’s chance at life.

C3i’s mission is to develop and manufacture cost-effective state-of-the-art integrated cell and gene therapies making it accessible to people in need.

Our values are Excellence, Responsiveness, Collaboration, Integrity, and Empathy. They define who we are and how we pursue our mission and vision.

We are small enough to care and big enough to deliver. Let’s talk!

Visit Website

Corning offers solutions for efficiently scaling up cell cultures for cell therapy from research to production.

Open and closed systems solutions supporting adherent cell culture scale-up include CellSTACK® and HYPERStack® vessels, the CellCube® circulation-based system, the novel high-yield Ascent® FBR platform, and polystyrene and Corning Vanish® dissolvable microcarriers.

Corning cell culture surfaces enhance the binding and growth of specialized and fastidious cell types in low and non-serum media environments and offer functional, structural, and surface charge modalities.

Corning supports suspension workflows with Erlenmeyer flasks, disposable spinner flasks, bags, and closed system accessories.

Corning customers are supported by Corning Field Application Scientists and Scientific Support Specialists with extensive expertise in cell biology and process optimization for cell therapy research and production. 

Learn more at 

Visit Website

Cryoport is the market leader in integrated temperature-controlled supply chain solutions for critical, irreplaceable products and materials in the life sciences industry. 

We are already trusted to support over 650 active clinical trials and leading commercial products worldwide - delivering unparalleled supply chain services for products, therapies and treatments requiring specialized temperature-controlled management. And, as the life sciences constantly evolve and advance, so do we.

Visit Website

With over 50 years of focus in the development and optimization of cell culture media, FUJIFILM Irvine Scientific is driven to develop scalable, innovative media for the life science, biotech, and biopharmaceutical fields.

Our expertise and understanding of the challenges within integrated end-to-end workflow solutions, paired with our legendary customer service and technical support, enables us to partner with customers to create complete, optimized media solutions, ready for scale-up, that help bring therapies to market faster.

Visit Website

LumaCyte’s advanced real-time bioanalytics platform, Radiance®, is a label-free, single cell approach for quantitative characterization of innate cellular responses, without the need for antibody or genetic labeling.

This revolutionary technology utilizes Laser Force Cytology™ (LFC) to measure subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells in response to their environment or treatment.

Visit Website

Marken is the clinical and advanced therapy subsidiary of UPS Healthcare. With Marken, Polar Speed and BOMI Group included, the UPS Healthcare network consists of 200+ locations worldwide.

Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 56 locations worldwide, while maintaining the leading position for cell and gene therapy services, direct-to-patient and home healthcare services, biological sample shipments and biological kit production.

Marken’s dedicated 2,600+ staff members manage 200,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 16,000+ home healthcare visits.

Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.

Visit Website

A nonprofit organization committed to clinical practice, education, and research, providing whole-person care to everyone who needs healing.

The needs of the patient come first. 

Visit Website

We at Sartorius support the biopharmaceutical and life science research industries to develop and manufacture medications from the first idea to production.

We’re in this together. For better health for more people.

At Sartorius, we empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine. 

At Sartorius, we empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.

Visit Website

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services.

As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients.

With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year.

Visit Website


The Association for the Advancement of Blood & Biotherapies (AABB) is an international, not-for-profit organization representing individuals and institutions who are instrumental in making biotherapies safe, effective, and available worldwide.

The Association works collaboratively to advance the field through the development and delivery of the AABB standards, accreditation, and education programs. Additionally, we work with our membership to drive policies that advance novel biotherapies research and increase patient access to biotherapies.

Our Biotherapies offerings help companies increase their speed to market through the identification of well-qualified partners, increased competence through credentialing and education and increased visibility in the biotherapies community.

Visit Website

Accellix was founded on the basis of creating a rapid, easy-to-use, automated cell phenotyping platform for point of need environments, focusing on cell therapy. Accellix is bringing next-generation analytical capabilities to its customers, enabling the measurement of critical quality attributes at every QC phenotyping interrogation point throughout the manufacturing process and the release of cell therapy products—when and where required.

Currently, these assays are performed on standard flow cytometers in centralized labs which require skilled technicians, high maintenance, a separate lab space, and a long turnaround time. There is a growing need for simpler more automated technologies that can fit seamlessly into centralized and de-centralized point-of-need models.

Accellix aims to bring the power of flow cytometry to the GMP manufacturing floor, automating the entire GMP cell phenotyping process from sample preparation to data analysis with the Accellix Platform. Accellix brings automated sample preparation, flow cytometry and data analysis directly into the manufacturing suite.

The Accellix team is an interdisciplinary group composed of skilled biologists, engineers, mathematicians, technicians and more with deep experience in all aspects of cell therapy in general and the immunotherapy field. Accellix has growing offices in Jerusalem, Israel and San Jose, CA.

Visit Website

Valuing Life, Granting Advanced Therapies to Patients- that Is Adva Biotechnology’s Vision and goal. 
Knowing the need for smart adaptive automation, and understanding that processes change and varies, the Adva biotechnology team developed the ADVA X3 - a fully controlled, flexible, and automated cell processing platform that enables full manufacturing process.
The ADVA X3 is basedon the unique CAMP® (Continues Adaptive Multi-Parameter) technology and enables the manufacturing of different applications, such as CAR-T, TCR, TIL, NK, Exosomes, Virses and More.
Adva Biotechnology’s unique team is composed of biologists, biotechnologists, engineers that bring their expertise to create novel and innovative technologies for advanced cell therapies. 

Founded in 1998, Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients worldwide rely on Aldevron-produced plasmid DNA, RNA, gene editing enzymes and more for biological research projects from discovery to clinical trials and commercial applications. These efforts help accelerate development of treatments for diseases such as cancer, infectious disease, pediatric disorders and rare diseases.
Aldevron specializes in cGMP manufacturing and is known for inventing the GMP-Source® quality system. Our mission is to be a partner in the development of medicines that improve patients’ lives while serving clients, employees, and the community, while constantly looking for new and better ways to give researchers the products and services they need.
Aldevron operates the largest cGMP plasmid DNA manufacturing facility in the world, located in Fargo, North Dakota, which serves as company headquarters, with additional facilities in Madison, Wisconsin, and Lincoln, Nebraska.

AmplifyBio will advance the quality of human health and save lives by creating next-generation platforms, tools, and services to amplify and accelerate the development of therapies and vaccines that will be accessible to millions of people.

Visit Website

AMSBIO is contributing to the acceleration of discovery through the provision of cutting-edge life science products and services for R&D. We provide solutions for studying cell motility, migration, invasion and proliferation.

We also offer solutions for organoid and spheroid culture, regenerative medicine and stem cell research. For PDX applications and organoid, spheroid, and pluripotent stem cell culture, AMSBIO offers two innovative hydrogel matrix products.

Extragel serves as a like-for-like replacement for Matrigel™, Geltrex™, and Cultrex™ Basement Membrane Extract (BME). On the other hand, MatriMix is a fully-defined alternative to current options, offering enhanced performance in various applications.

Visit Website

Anemocyte is an Italian Biotech Manufacturing Organization with a strong focus on the development, manufacturing, and analytical services to address needs in the field of:

  • mRNA – mRNA manufacturing (R&D) for vaccines and therapeutic treatments;
  • pDNA – Plasmids manufacturing (R&D, Hiqh-Quality, and GMP) for Viral Vector and mRNA.

Our experience:
> 20 years of development and manufacturing experience (from R&D to GMP) in the field of Cell and Gene Therapies and Nucleic Acids.

Visit Website

Applied StemCell is a leading provider of customized cell and gene therapy solutions, offering a wide range of specialized services, including IP-based genome editing expertise in cell therapy development, and comprehensive end-to-end cGMP cell manufacturing for innovative cell gene products. With over 15 years of global experience, Applied StemCell is at the forefront of the cell and gene therapy field, actively supporting advancements in gene editing and cell therapy.

The company employs two powerful platforms, Genome Editing (TARGATT) and cell products, including iPSCs/MSCs. Their unwavering commitment is geared towards assisting clients in developing groundbreaking therapeutics. Beyond conventional offerings, Applied StemCell provides GMP gene-editing and cell manufacturing services (Phase I, II, III), complemented by flexible cell banking options.

Strategically located in California, Applied StemCell operates a cGMP facility with 5 dedicated suites. With a 7-year ISO 13485 certification, adherence to cGMP, and compliance with 21 CFR Part 11, 210, 211, and 1271, our company stands as a premier partner. Spanning over 15,000 sq. ft. of dedicated research and facility space, we seamlessly integrate innovation, expertise, and commitment to propel the ever-evolving field of cell and gene therapies.

Visit Website

ASEPTIC TECHNOLOGIES develops, manufactures and markets innovative aseptic solution for the BioPharmaceutical industry.

Its equipment and devices are designed to provide safer & easier operations for aseptic fill and finish, the best-known being the AT-Closed Vial® technology.

The AT-Closed Vial® is manufactured in ISO 5 clean room with the stopper secured in place and gamma sterilized. Vial size ranges from 1 to 50ml. The filling of these ready-to-use vials is performed by a special needle piercing the stopper and dispensing the drug product. The stopper is then immediately resealed by a laser and a cap is snap-fitted on it. Various equipment offer an easy scale-up from manual to fully automated operation.

The benefits of the technology are: better sterility assurance, reduced investments, increased safety during whole supply chain, strong operating cost reduction.

The AT-Closed Vial® technology is widely used in the Cell and Gene Therapies as it offers uncompromised container closure integrity even during storage at cryogenic temperature.

Visit Website

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world.

We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality.

Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners.

Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please visit our website at 

Visit Website

Pioneering the future of cell & gene therapies with market-leading digital solutions.

In the dynamic realm of cell & gene therapies, Autolomous Ltd stands out as the vanguard solution provider of advanced manufacturing management systems. With a global footprint, Autolomous is redefining the paradigms of the industry by offering fully integrated, digitized, and automated supply chain software solutions.

Harnessing the potential of cutting-edge technologies like Ledger technology and AI, Autolomous ensures that its solutions not only meet but anticipate both current and evolving regulatory standards. This proactive approach ensures an impeccable compliance record, positioning manufacturers to optimize their processes, reduce operational costs, and expand the reach of cell & gene therapies to an ever-growing patient demographic.

Central to Autolomous' innovative suite is the autoloMATE® platform. Beyond being a digital tool, autoloMATE® emerges as an indispensable ally for manufacturers. It's purposefully designed to enhance efficiency, foster scalability, and streamline GMP processes, all while ensuring the timely and compliant release of cell & gene therapies.

Autolomous Ltd remains committed to its mission: leveraging technology to drive excellence, accelerate growth, and ultimately, deliver the promise of cell & gene therapies to patients worldwide.

Visit Website

AventaCell BioMedical Corp. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration.

Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production.

The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development.

Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines.

AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.

Visit Website

Brooks Life Sciences Services and Products business is rebranded under the creation of a new identity – Azenta Life Sciences. Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Azenta Life Sciences encapsulates our commitment to helping customers reach new heights in their pursuit of scientific progress. By integrating our industry-leading capabilities, Azenta Life Sciences enterprise-wide sample exploration and management solutions will accelerate discovery, development and delivery, with greater speed and precision.

At Azenta, we strive to keep elevating each other, our customers’ work and our industry – building a healthier world for people everywhere.

Visit Website

BioCanRx is Canada’s Immunotherapy Network.

Our vision is to turn all cancers into curable diseases. We are a network of scientists, clinicians, cancer stakeholders, academic institutions, NGOs and industry partners working together to accelerate the development of leading-edge immune oncology therapies for the benefit of patients.

As a leader in the translation, manufacture and adoption of cancer immunotherapies, we invest in translating world-class technologies from the research lab into clinical trials.

BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities. We train and develop the talent needed for a thriving Canadian health biotechnology sector.

BioCanRx receives funding from the Government of Canada and support from industry, the provinces and charities.

Visit Website

BioInVision, based in USA, offers imaging instrumentation and methodologies critical to preclinical studies.

The unique CryoViz instrument, utilizes the patented hi-resolution blockface-imaging technology, to capture microscopical anatomical and molecular fluorescence imaging of laboratory small animals such as a mouse, rats or organs excised from them with single-cell sensitivity.

With its sub-10-micron-scale imaging, CryoViz allows one to detect even single stem or cancer cells anywhere in a mouse.

The technology is also offered as a service and is targeted to a variety of biomedical applications including stem cell homing and bio-distribution, cancer micro-metastatis, imaging agents, drug discovery, tissue engineering, mouse phenotyping etc.

Visit Website

BioLamina offers an expansive portfolio of human recombinant laminin proteins for a variety of applications. With our cell therapy grade products, we can support scientists throughout their cell therapy development process – from concept to commercialized therapy.

Our Biolaminin® substrates are defined, full-length laminin cell culture matrices that can be used for a variety of applications, like the expansion of human pluripotent stem cells and differentiation and maintenance of different specialized cell types, such as hepatocytes, cardiomyocytes, and neural cells.

The biologically relevant cell-matrix interaction gives more consistent cellular responses, more standardized experiments, improve the differentiation potential, and keep adult cells mature for a significantly longer time in culture than has previously been feasible.

Our Biosilk® 521 product is a new 3D biomaterial that combines the biological instructive cues from ECM laminins with the mechanical and topological support from silk, allowing engineered, controllable, and tunable organoids.

BioLamina is a Swedish biotechnology company with a global presence and our laminin technology has been scientifically validated in many high impact journals.

Visit Website

For over 30 years, Bionique Testing Laboratories continues to be a trusted partner and global leader in Mycoplasma Testing Services for the life science industry.

We offer the full range of testing services from relevant compendia (USP <63> Mycoplasma Test) to a GMP compliant Real-Time PCR assay to support the development and clinical manufacturing of cell & gene therapies.

From discovery to commercialization, our capabilities extend to method development and validation of rapid microbial methods to meet global regulatory requirements. Bionique delivers testing services that meet the highest quality standards and offers the fastest turnaround times in the industry.

Visit Website

The market’s most experienced provider of apheresis derived products, the BioSharing Network is a partnership between eight US blood centers.

The network has over two million donors and has decades of experience recruiting donors and performing apheresis procedures.

Our network provides GMP (mobilized & non-mobilized) leukopacks, bone marrow, cord blood and perinatal tissue, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing.

With multiple donor rooms, clean rooms for manufacturing, and strong logistics teams, we are a the most reliable provider in the market.

Visit Website

BioSpring is a leading industry expert in oligonucleotide science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I-III, in addition to preclinical material supply and diagnostic manufacturing.

We are a privately owned company of over 600 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle.

Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our quality and expertise, guided by our passion for innovation and more than 26 years of experience.

Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible. We are driven by our desire for a healthier world. Restoring hope in patients living with debilitating diseases is our daily motivation to progress novel nucleic acid-based therapies to their commercial promise.

Visit Website

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services.

Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results.

Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.

Visit Website

The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) is the most experienced and successful facility of its kind in Canada, having manufactured more than a dozen different cell and virus-based products for human clinical trials in Canada, the United States, Europe and Asia.

With eight manufacturing suites and 40 full-time staff, BMC offers a full range of services to both academic and corporate partners, including process development, manufacturing and fill-finish, all done according to Good Manufacturing Practice (GMP) standards.

Over the last 15 years, BMC has manufactured:

  • Viral immunotherapies for cancer
  • Mesenchymal stem / stromal cells
  • CAR-T therapy (cells plus lentivirus)
  • Genetically engineered endothelial progenitor cells
  • Adeno Associated Viruses for gene therapy
  • Vaccines for COVID-19

BMC also leads the only hands-on training program in Canada in biotherapeutics manufacturing, in partnership with Algonquin College, the University of Ottawa and Mitacs.

Visit Website

BioThrust is the inventor of the bionic bioreactor for next generation cell therapy manufacturing. The system offers an innovative platform for the scalable, efficient and unprecedented expansion and differentiation of stem and immune cells such as MSCs, iPSCs, NK-cells, T-cells or exosomes.

The disruptive core technology if this novel bioreactor is the BioThrust Membrane Stirrer which for the first time in the world enables a completely bubble-free aeration of cell cultures with sufficient gas entry. In recent cell culture pilot runs, this technology more than doubled the cell culture yield and completely avoided foam.

With this scalable and highly efficient bioreactor platform, BioThrust has the vision to make stem cell therapies available for everybody.

Visit Website

Broken String Bioscience’s technology platform, INDUCE-seq™, supports the development of cell and gene therapies that are safer by design.  

INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes.

The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. 

Visit Website

CARR Biosystems UniFuge single-use Centrifuge systems provide separation processes with reliably high cell viability and separation efficiency, improving yield for manufacturers of cell therapies, gene therapies, recombinant therapeutics, vaccines and cultured meat products.

Today, top biopharma companies manufacture licensed products using our fully closed, automated systems that are optimized to recover whole cells or supernatant.

To learn more about CARR Biosystems and our scalable single-use separation systems.

Visit Website

Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics.

A full-service partner for plasmid DNA, viral vectors, vaccines and autologous and allogeneic cell therapies, Catalent has a global network of small- and large-scale clinical and commercial manufacturing facilities in the U.S. and Europe.

Visit Website

CCRM, a Canadian public-private partnership established with seed funding by the Government of Canada, the Province of Ontario, and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.

A network of academic researchers, leading companies, strategic investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, funding and infrastructure. CCRM sources and evaluates intellectual property from around the globe, offers various consulting services, conducts development projects with partners, and establishes new companies built around strategic bundles of intellectual property.

CCRM has a fully resourced research facility used to both evaluate and advance technologies, a centre for process and analytical development and advanced manufacturing, and a GMP facility within a 40,000 square foot space. In 2022, CCRM established OmniaBio Inc., a commercial-stage CDMO for manufacturing gene-modified cells and viral vectors for cell and gene therapies.

CCRM’s model has been adopted outside of Canada in CCRM Australia and CCRM Nordic. CCRM is hosted by the University of Toronto and was launched in Toronto’s Discovery District on June 14, 2011. Visit us at

Visit Website

The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world.

Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation.

The Cell and Gene Therapy Catapult works with Innovate UK. For more information, please visit or visit

Visit Website

Cell Manufacturing Technologies (CMaT) is an NSF-funded multi-institutional engineering research center (ERC) with world leading expertise in transforming the manufacturing of cell-based therapeutics into large-scale, low-cost, reproducible and high-quality engineered systems.

CMaT is dedicated to developing new fundamental knowledge; transformative new tools and technologies; integrated next-generation cell-manufacturing platforms; a diverse, inclusive, and well-trained workforce; and best practices, standards, and global thought-leadership. 

Visit Website

CellFE is an innovative microfluidics company whose mission is to make cell therapies accessible for all by streamlining the development process.

The company has developed a novel cell engineering platform with highest cell health and payload delivery with streamlined and automated workflows.

Benefits include increased cell yield and reduced expansion times that translate to shorter vein-to-vein times and lower manufacturing costs.

CellFE is committed to its partners’ success through its close collaborations to solve challenges facing the delivery of advanced cell therapies.

Visit Website

Cellular Highways, has developed the next generation of automated high-throughput, scalable, gentle cell sorting instruments for research, diagnostic and therapeutic applications.

Powered by VACS (vortex actuated cell sorting), a new microfluidic cell sorter technology, our instruments reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms, thus making cell sorting accessible to every laboratory as well as enabling new clinical applications.

Our first product, Highway1 presents advantages for speed (high rates for purity and enrichment modes), gentleness (no loss of cell viability and function) and sterility/biocompatibility.

Visit Website

CellVec is a certified GMP gene therapy Contract Development and Manufacturing Organisation (CDMO) that is a specialist provider of custom viral vectors for pre-clinical and clinical applications.

With the use of our lentivirus-based CellVec Vector Platform, we set ourselves apart through the ability to overcome current technological bottlenecks in the upscale production of viral vectors and develop novel gene transfer technologies for advanced therapies in order to facilitate the advancement of our client’s products from bench-to-bedside for clinical applications."

Visit Website

At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development.  

We can support your cell and gene therapy program every step of the way, from early discovery to the clinic.  Relevant products include leukopaks, isolated immune cells, plasmids and viral vectors.

Services include CDMO manufacturing, toxicity/toxicology studies, to analytical release testing of your cell line characterization, biosafety and potency testing.  

Our global footprint, team of experienced professionals and unsurpassed portfolio of integrated services are dedicated to supporting you to help get your product to patients faster.

Visit Website

Founded in Denmark in 1997, ChemoMetec has grown into a global supplier of automated cell counting and analysis equipment. We are dedicated to developing and manufacturing highly precise analytical instruments, empowering the life science industry to achieve reliable and consistent results.

Our core focus lies in producing innovative cell counting solutions like the Xcytomatic® and NucleoCounter® series. These instruments are recognized for their versatility and precision, making them ideal for applications ranging from cell line development, cGMP biologics manufacturing, clinical and commercial manufacture of cell and gene therapies, and academic research.

With headquarters in Allerod, Denmark and multiple US offices, ChemoMetec offers dedicated support through its team of field application scientists and field service engineers. Our support team ensures seamless adaptation, installation, and service of our products so that our customers obtain quality results.

Beyond providing state-of-the-art cell counters, ChemoMetec strives to be a true partner in the advancement of biopharmaceutical research and development. We actively engage with innovation hubs and life science incubators, collaborating with emerging biotech to understand their unique needs and challenges. Our curiosity and commitment to reproducible scientific methods fuels our continuous innovation in cellular analysis. No matter the cell type, sample, or user, our products provide consistent and reliable results."

    Visit Website

    Curi Bio’s preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi Engine™ is a comprehensive, bioengineered platform that integrates human iPSC-derived cell models, tissue-specific biosystems, and AI/ML-enabled phenotypic screening data.

    Curi Bio’s suite of human stem cell-based products and services enable scientists to build more mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new drugs in development.

    By offering drug developers an integrated preclinical platform comprising highly predictive human stem cell models to generate clinically-relevant data, Curi Bio is closing the gap between preclinical data and human results, accelerating the discovery and development of safer, more effective medicines.

    Visit Website

    Cytek® Biosciences is a leading cell analysis solutions company advancing the next generation of tools with patented Full Spectrum Profiling™ (FSP™) technology.

    Cytek’s portfolio includes the Cytek Aurora™, Cytek Aurora™ CS and Cytek Northern Lights™ systems, Amnis® and Guava® products, reagents, software, and services to provide comprehensive solutions for customers. 

    Visit Website

    Deepcell's AI-powered REM-I platform is enabling a new scale of cell biology research and single cell analysis.

    Deepcell's platform leverages its artificial intelligence model, the Human Foundation Model, to identify and sort cells based on morphological distinctions without labels to help power basic & translational research.

    Visit Website

    Defence Therapeutics is a Canadian publicly-traded biotechnology company developing the next generation anti-cancer therapeutics using its own proprietary platform.

    The core of Defence Therapeutics platform is the ACCUM® technology, a platform enabling the precision delivery of any biomolecule in its most intact form to intracellular targets. More specifically, ACCUM® is a lipopeptide composed of a bile acid fused to a peptide sequence, which once captured via endocytosis, creates a series of biochemical reactions causing endosomal membrane destabilization and/or rupturing.

    This process allows fast and efficient release of captured molecules into the cytoplasm before a decrease in endosomal pH or lysosomal protease activation even occurs. With a solid pipeline in hand, Defence Therapeutics is exploiting the ACCUM® technology for the development of various products including: i) anti-cancer vaccines (mRNA-, DNA-, protein- or cell-based) targeting different solid tumor indications, ii) antibody-drug conjugates (ADC) with 50 to 100-fold improved therapeutic potency, and iii) various ACCUM® derivatives (e.g. AccuTOX®) exhibiting anti-cancer activity and used as direct solid tumor injectables.

    Defence Therapeutics recently obtained FDA clearance for its Phase I trial on the use of its anti-cancer molecule AccuTOX® for melanoma, and is currently working to obtain a second clearance for testing its first-in-class universal off-the-shelf cell-based cancer vaccine for solid tumors. 

    Visit Website

    Clean cells is a pharmaceutical establishment that offers :

    • Quality control in biological safety and functionality in biopharmaceutical products in a regulatory context in various applications, such as recombinant proteins, therapeutics antibodies, viral vaccines and cell and gene therapy product. 
    • Production of GMP cell banks and virus seed stock and associated quality control as one stop shop. 

    Visit Website

    c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products.

    The company uses world-class enzyme engineering and production technologies to provide its partners in the food and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. c-LEcta is part of the Kerry Group.

    Visit Website

    Chryotherm as  a leading supplier of storage, transfer and transport system, has been a renowned manufacturer of products and services for cryogenic technology for more than 55 years.

    The network-compatible BIOSAFE® systems are biorepository freezers, available with narrow and wide neck openings, for the preservation and long -term storage of biological and medical samples. Up to 120,000 samples in 2ml vials fit into one BIOSAFE® 2400.

    You always keep the overview with the new BIOSAFE® i-track for your comfortable sample management!

    Visit Website

    CSafe offers the most comprehensive suite of thermal shipping solutions for pharmaceutical cold chain shipping needs around the world. With a “patient-first” focus, deep industry expertise and commitment to innovation, CSafe delivers industry-leading products in both the active and passive segments.

    CSafe is the only provider with an end-to-end portfolio including active and passive bulk air cargo, parcel, cell and gene and specialty last-mile use cases and the ability to meet the complete range of pharma cold-chain shipping requirements with industry-leading quality and reliability.

    Offering nearly any size, duration and temperature – CSafe is at the heart of your cold chain.

    Visit Website

    With Mayo Clinic at its heart, Destination Medical Center (DMC) is the largest public-private economic initiative in Minnesota and the catalyst for growth in Rochester.

    Growth is anchored in Discovery Square, a 16 block innovation district built in collaboration with Mayo Clinic in a highly connected urban life science hub.

    Visit Website

    Digi-Trax® is instrumental in transforming healthcare organizations across the world by applying bar coding and intelligent hardware.  

    As a technology solutions partner, we enhance client data structures while mitigating risk and improving workflows. Now and into the future, we are with you every step of the way to implement and support the right strategy at your facility.

    Visit Website

    Discovery Life Sciences’™ Cell and Gene Therapy Division, AllCells, is the industry leader in the procurement and customization of human-derived hematological tissues and services.

    Discovery collects from strategically located facilities and processes materials in adjacent laboratories.

    We provide high quality GMP and RUO products and services that aid global life science researchers and bio-manufacturing organizations to develop immunotherapies, vaccines, and cell and gene therapy starting material. 

    Visit Website

    In order to provide safe, effective and economically viable cell therapy solutions, DuoGenic StemCells Co. focus on the development of high-quality and certified stem cell culture medium and other cell culture-related services.

    Based on the basic research and clinical evidence, we also develop the PCP treatment which is a peripheral blood cell therapy treatment for degenerative disease such as knee osteoarthritis (OA Knee).

    We are looking for prospective distributors and business partners to increase the outreach of our products.

    Visit Website

    DYNEX Technologies, Inc. is a pioneer in the design and manufacturing of fully automated ELISA microplate technology. For over 70 years, DYNEX has earned a global reputation for delivering diagnostic and immunoassay instrumentation that maximize reagent performance and optimize laboratory productivity, with complete assay accuracy on which clinicians depend.

    Quality is the cornerstone of the DYNEX brand. The company’s U.S. manufactured, ISO certified instruments offer scalable processing solutions to achieve optimal workflow proficiency for laboratories of all sizes and specialties.

    DYNEX Technologies supports clinical diagnostic communities in over 120 countries worldwide and is headquartered in Chantilly, Virginia. Learn more at

    Visit Website

    ECL2 is the U.S. provider of Ideagen Quality Management (IQM) formerly Q-Pulse, a Quality Management System software implemented in over 80 countries worldwide. ECL2 currently supports numerous labs and has been featured in the newest edition of a book written by a widely respected expert on cellular therapy. 

    Paired with our expertise within the life sciences area and specific to cellular therapy and blood banking, we are in the best position to advise our clientele on best practices relating to the automation of their programs. All our QMS consultants have been Quality professionals themselves and have been responsible for their own quality systems. 

    We make the process a seamless one, because we’ve been through it.  ECL2 provides a complete solution starting from the initial sale, to delivering training and configuration while also supporting you in your ongoing needs. Our consultants also provide consulting services to those that require additional guidance in developing their Quality Management Systems.

    IQM comes with all the modules integrated for a comprehensive solution. Allowing you to stay on top of training requirements with visual aids such as matrix views, equipment maintenance based upon a fixed period or on usage, it provides a complete document control solution linked to training plans, manages workflows for corrective and preventative actions, complaints, and anything else requiring a workflow. IQM provides a workload dashboard, so you know what is required of you, your team or entire organization. IQM also includes audit management, reporting and trending. Please stop by and see us!"

    Visit Website

    Ecolab Life Sciences supports safety, compliance and operational efficiency for global pharmaceutical and personal care manufacturers by delivering a comprehensive programmatic approach to contamination control, cleaning and disinfection.

    Our end-to-end contamination control solutions, enhanced by Bioquell technology, allow our customers to have safer products and processes by reducing their risks.

    Our offerings meet regulatory requirements, support compliance initiatives, and realize operational efficiencies while achieving cost savings for our customers worldwide.  

    Visit Website

    Entegris, Inc. (NASDAQ: ENTG) is a world-class supplier of advanced materials and process solutions for the semiconductor, life sciences, and other high-tech industries. For over 50 years, we have been committed to solving our customers’ most demanding process challenges through a broad solutions portfolio, collaborative and innovative product development, and a focus on science and applications knowledge.

    Entegris has ~9,000 employees throughout its throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service, and/or research facilities throughout United States, Canada, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea, Taiwan and the United Kingdom. Our highly skilled team members, facilities and resources are right where you need them in order to help you solve your most advanced technology challenges.

    Visit Website

    Eppendorf is a leading life science company.

    It was founded in Hamburg, Germany in 1945 and has more than 5,000 employees worldwide. The company has subsidiaries in 25 countries and is represented in all other markets by distributors.

    By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has grown to a global player in the bioprocess marketplace.

    With a comprehensive offering of single-use and traditional products, the Eppendorf bioprocess portfolio satisfies the demands from research and development through the production of mammalian, microbial, insect, plant and algae cells.

    Visit Website

    Esco Lifesciences is a world-leading life science company with a diversified portfolio and sales in over 100 countries. As a manufacturer of laboratory and biopharma equipment, and IVF medical devices, Esco offers tailored solutions that fit the needs of laboratories in various industries.

    Esco Lifesciences contributes to meet the challenges of the 21st century with a diverse range of business units. The company continuously innovates its products to help the clinical and industrial laboratories achieve successful conclusions in research and development, quality control, and analysis.

    We continue to provide reliable world-class equipment to help pharmaceutical companies make their products safer and more cost-effective. And with the increasing demand of the IVF industry, we have developed efficient ART equipment to enable equitable access to infertility care.

    Visit Website

    Starting with highly qualified, reliable donors we manufacture cells characterized to your requirements, reducing variabilities in clinical responses, and increasing your probability of success in your trial.

    Trust Excellos as your cell therapy CDMO to support your programs in adoptive cell therapies including: TIL Therapy, Autologous and Allogeneic CAR-T/NK Therapies, and TCR Therapy.

    Visit Website

    Exodus Bio, specializes in cutting-edge exosome isolation technology, enhancing life sciences research and industrial applications globally.

    Their automated systems, known for efficiency and purity, support advancements in cell and gene therapy.

    With a presence in North America, Asia-Pacific, and Europe, Exodus Bio aims to be a pivotal force in biotechnology, contributing to global health innovations.

    Visit Website

    FACT is a non-profit corporation founded for the purpose of voluntary inspection and accreditation in the field of cellular therapy, cord blood banking, and regenerative medicine.

    The objective of FACT is to improve the quality of cellular therapy through peer-developed standards, education and accreditation for the benefits of patients.

    Visit Website

    FUJIFILM Wako Chemicals Europe GmbH established itself as a comprehensive chemical supplier and distributor of high quality Excipients and Fine Chemicals for the pharmaceutical and biopharmaceutical production in Europe.

    We actively support research & development and production of pharmaceutical products through manufacturing excellence and innovation in GMP raw materials, culture media.

    Visit Website

    Genesis BPS is a global manufacturer and supplier of precision equipment to clinical laboratories, life science customers, blood collection and cellular therapy organizations. Our product portfolio represents quality and consistency in a world of ever-changing requirements for processing, collection and storage.

    ZipThaw is a dry thawing device setting a new standard for thawing applications. ZipThaw provides consistent, efficient and gentle thawing and warming of fluids requiring high viability. This lightweight, portable unit has a compact footprint, low capital cost and minimizes cross contamination with the use of patented disposables. ZipThaw reduces operating costs and requires virtually no maintenance. ZipThaw has two independent chambers that that provide a hygienic and fast solution to meet your thawing requirements.

    Visit our booth to learn more about our tools for science including Dry Thawing Devices, Waferless Sterile Tube Welder’s, Tube Sealers, Collection Devices, Therapeutic Phlebotomy products, specialty blood bags and a whole lot more.

    To learn more, visit or call one of our representatives at 866-71-BLOOD. Genesis BPS...Technology is in our blood!

    Visit Website

    Genezen is a contract development and manufacturing organization (CDMO) with a decade’s experience at the heart of the rapid growth in the gene and cell therapy market.

    Genezen is a leader in the supply of retroviral vectors, lentiviral vectors, and AAV. Led by an extremely experienced team, a science-first approach influences continual investment in scalable, high-yield manufacturing processes and best-in-class technologies.

    With continual investment in a multi-location footprint strategically connected to advanced modality hubs, Genezen is expertly placed to meet the needs of fast-moving gene and cell therapy innovators. For more information about Genezen, please visit

    Visit Website

    GenScript is the world’s leading technology and service provider of life science R&D and manufacture.

     Built upon its solid gene synthesis technology, GenScript Biotech is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization (CDMO) platform, the industrial synthetic products platform, and the integrated global cell therapy platform.

    With an unwavering commitment to advancing these fields, we empower researchers and biopharmaceutical companies to drive groundbreaking discoveries and develop life-changing therapies. Our expertise in Non-viral Cell Engineering Platforms (CRISPR/Cas Plasmids, sgRNA, Cell Lines, HDR templates, IVT mRNA), Viral Cell Engineering Platforms (GMP/CMC Plasmid, Viral Vector Packaging), and Antibody & Peptide Services, positions us at the forefront of innovation.

    We provide tailored solutions, ensuring that our partners have the tools and support needed to accelerate the development of cell and gene therapies. GenScript's dedication to quality and compliance with stringent regulatory standards ensures the safety and effectiveness of these therapies, ultimately offering hope to patients grappling with previously incurable conditions.

    As pioneers in this dynamic field, we invite you to join us on this extraordinary journey to unlock the potential of gene and cell therapy, transforming the future of healthcare for the better.

    Visit Website

    Germfree has over 60 years of experience designing, engineering & manufacturing pharmaceutical equipment, laboratory equipment, hospital pharmacy equipment and turnkey mobile & modular cGMP cleanroom buildings. Germfree’s bioGO® mobile cleanrooms help deliver on the promise of distributed manufacturing by providing fully turnkey production suites that can easily be deployed at the point of care. Our offsite-built modular cleanrooms reduce risk, time and complexity during facility construction while providing a permanent solution that meets or exceeds the standards of traditionally built facilities. 

    Additionally, Germfree produces a full line of pharmaceutical, pharmacy, and laboratory equipment including: USP <797> and <800> compliant Biosafety Cabinets & Laminar Flow Workstations. Germfree is recognized as a leading manufacturer of Class III Biosafety Cabinets to provide containment in the most advanced BSL-3 & BSL-4 labs. Germfree systems have been purchased by more than 6,000 institutions and companies in the U.S. & 60 other countries worldwide.

    Visit Website

    With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows.

    The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science.

    Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

    Visit Website

    Grifols Bio Supplies is a trusted source for human-derived materials used in pharmaceutical and diagnostic manufacturing, as well as in life science research.

    These materials are collected from Grifols' own network of blood and plasma centers in the USA and Europe.

    Visit Website

    Halo Labs knows aggregates and particles. Aura® can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants.

    A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.

    Visit Website

    Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products.

    In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.

    The systematically structured portfolio of up-scalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.

    Visit Website

    Hitachi delivers innovations that answer society's challenges.

    With our talented team and proven experience in global markets, we can inspire the world.

    Visit Website

    ICCBBA is the not-for-profit, nongovernmental international standards organization responsible for the management and development of the ISBT 128 Standard.

    Used in more than 85 countries across six continents and disparate health care systems, ISBT 128 is the global standard for the terminology, identification, coding, and labeling of medical products of human origin including blood, cell, tissue, milk, and organ products. 

    The Standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors and patients worldwide.

    Visit Website

    Our company is a trading company specializing in chemicals that has been in business for 133 years.

    We focus on handling regenerative medicine related products and services, and are the sole distributor of Solaris Bio's culture media.

    Visit Website

    Intellitech manufactures and sells the i-FILL® family of pumps – qualified for live cell transfer, high-value product handling, and unmatched, repeatable dispense accuracy.

    Intellitech designs and manufactures standard and custom single-use systems to meet challenging requirements. We cover the spectrum from R&D to GMP with prototypes through full-scale production/packaging of single use assemblies including fluid path for injectable drug product.

    Visit Website

    Located at the HudsonAlpha Institute for Biotechnology in Huntsville, AL USA, iRepertoire
    was the first company to develop and patent multiplex amplification technologies for
    comprehensive and inclusive sequence analysis of the adaptive immune system. Our
    proprietary amplification technologies enable complete and unbiased immune profiling.
    • Comprehensive 7-chain TCR and BCR analysis
    • Physically paired receptor chains from FACS isolated single cells
    • Flexible analysis for either DNA or RNA
    • Compatible with low sample quantities, rare, and difficult samples (i.e. FFPE)
    • Expert support from study design planning through exploratory data analysis
    Over the past decade, iRepertoire has continued to improve upon our legacy technology,
    amplicon rescue multiplex PCR (arm-PCR), by developing new approaches and enabling new
    applications. Whereas arm-PCR can inclusively amplify the expressed V(D)J receptor
    sequence in either B- or T-cells with great sensitivity, dimer avoided multiplex PCR (dam-
    PCR) enables unbiased amplification of all seven B- and T-cell receptor chains
    simultaneously from a single assay.
    Moreover, the inclusion of unique molecular identification tags prior to PCR amplification enables downstream bioinformatic error correction and robust data QC. Continuing as scientific thought leaders in the industry, we developed iPair, the first single cell immune receptor sequencing service to capture the cognate pairing of receptor chains from rare effector cells to determine antigen specificity and enable downstream reverse engineering for immunotherapy.

    Visit Website

    ISCT Institute of Training and Development is the Global Leader in CGT Workforce Development.

    Our programs are developed based on ISCT's translation-focused framework to address the training needs in critical topics across scientific research, pre-clinical, biomanufacturing, regulatory, safety, and patient access.

    ISCT Institute of Training and Development programs are developed and delivered using industry training best practices and certified by one of the leading international accreditation bodies.

    Visit Website

    Matrixome, Inc. is an Osaka, Japan based, biotechnology company created via a venture between Osaka University’s Institute for Protein Research and Tokyo based Nippi, Inc. Matrixome, Inc. was born out of the decades of research by Professor Sekiguchi and his research into the Extracellular Matrix (ECM) and creating the iMatrix™ product line.

    Our flagship product, iMatrix-511, is a revolutionary recombinant laminin E8 fragment protein that enables users to skip pre-coating plates, enabling automation for research, production, and cell imaging.

    Our main substrate works with iPSC, hESC, and mesenchymal stem cells, with other isoforms enabling definition into a myriad of tissue types such as cardiomyocytes, neuronal and endothelial to name just a few. Manufacturing is handled in Japan by a company with more than 100 years of experience, in brand new, state of the art clean rooms following the strictest of protocols.

    Our clinical grade version, iMatrix-511MG, is also approved by the Japanese government’s Pharmaceuticals and Medical Devices Agency for clinical research. With use in hundreds of peer-reviewed publications, by Nobel laureates, big pharmaceutical companies, in published clinical research, and in ongoing clinical trails it is a product you can trust with ease to further your research and meet your clinical production needs. 

    Visit Website

    Mekonos is using its novel cell-engineering platform to create a future where personalized medicine is accessible to all. By combining cutting-edge silicon nanoneedle technology, microfluidics, and proprietary surface chemistry, Mekonos' platform enables the efficient delivery of multiplexed cargo into even the most fragile of cells.

    Mekonos' non-viral approach offers unprecedented viability, precision, and control in molecular payload delivery, addressing key challenges in cell and gene therapy production – targeted delivery, cell survival & potency, and dose regulation (which translates to clinical safety).

    Mekonos offers collaborators a scalable solution to seamlessly move from research and discovery applications all the way through manufacturing and opens the doors to a new world of possibilities, including complex genetic modifications and challenging cell types currently inaccessible with conventional delivery technologies.

    Mekonos is headquartered in San Francisco Bay Area and backed by leading healthcare and technology investors. For more information, please visit and follow us on LinkedIn.

    Visit Website

    Mill Creek Life Sciences was the first company to commercially sell human platelet lysate (hPL). Born in a cGMP cell therapy lab, our human platelet lysates have been used to grow cells for thousands of patients globally in more than 50 Phase I, II, and III clinical trials for more than a decade.

    Our hPL products are derived from human platelets and offer unparalleled cell growth in cellular therapy. Mill Creek Life Sciences is committed to discovering and applying innovative approaches to cellular therapy and patient care.

    Our leading products are PLTGold® and PLTMax®, with gamma irradiated versions available. Initially developed for use with MSCs, our human platelet lysates have evolved into a platform technology that has been used with successful results with many other cell types and applications, including 2D and suspension cultures, as well as organoids. 

    Additional cell types grown with our products include T cells, NK cells, tumor cells, endothelial cells, iPSCs, and more. Mill Creek Life Sciences was founded with a singular purpose in mind: to bring new solutions to accelerate cellular therapies for patients.

    For us it is about quality, innovation and customer service. We work closely with our customers, helping fulfil their needs and supporting them through analyzing and troubleshooting specific applications when needed.

    Visit Website

    Distribution of molecular biology contamination control products for biopharma and research.

    Visit Website

    Mirus Bio revolutionized transfection over 25 years ago with the introduction of its flagship product, TransIT®-LT1.

    Pioneering new delivery solutions, such as TransIT-X2®, Mirus is a critical supplier of novel transfection reagents.

    With the introduction of TransIT-VirusGEN®, Mirus expanded expertise to virus manufacturing, supporting researchers from discovery to clinic. 

    Visit Website

    Empowering every scientist to make discoveries one cell at a time, NanoCellect offers modern and simple technologies for cell-based assays.

    With a bench top microfluidic cell sorter, single cell dispenser, and sterile microfluidics cartridges to analyze, sort or plate, scientists now have access to intuitive flow cytometry solutions for sorting fragile samples, which yields higher viability cells, and minimizes the chance of contamination.

    Ideal for cell line development, gene editing, single cell genomics, and antibody discovery, cell sorting has never been so accessible to every lab.

    Visit Website

    NanoEntek is a leading innovator in the field of life science research, providing state-of-the-art products and solutions to laboratories and researchers worldwide.

    With a commitment to advancing scientific discovery, NanoEntek has established itself as a trusted name in the industry. 

    Founded in 2000, NanoEntek has continuously pushed the boundaries of life science research. The company's mission is to empower scientists with innovative tools that enhance their ability to explore and understand biological systems.

    Over the years, NanoEntek has achieved significant milestones, including the development of cutting-edge technologies that have revolutionized cell counting analysis, and imaging.

    Visit Website

    Nanotein Technologies, Inc. is a Berkeley-based biotech startup company that makes next-generation Cell Therapy reagents using their unique platform technology, NanoSpark. 

    Nanotein has developed and launched soluble, protein-based, expansion and activation reagents, including STEM-T for high stemness in CD8+ T cells, EVEN-T, a first-in-class reagent to modulate the CD4+:CD8+ T cell ratio, and GROW-NK - a first-in-class feeder-free, NK cell activation expansion reagent.

    All products are currently available for purchase and research use at this time, with first GMP product to launch for T cells and NK cells through out the second half of 2024.

    Visit Website

    NecstGen is a non-profit CDMO and centre of excellence for Cell and Gene Therapy, located in a purpose-built GMP facility on the largest bio-cluster in the Netherlands, Leiden Bio Science Park.

    Here, NecstGen provides critical contract development, manufacturing and rental services to academic and industrial therapy developers to deliver a new generation of therapies to patients. 

    NecstGen offers:

    • Full contract manufacturing services for Cell Therapy and Viral Vector;
    • Process design, scale-up, optimisation and automation for Cell Therapy and Viral Vector;
    • Assay development for in-process, release, and potency;
    • Cleanroom rental including services for QA, QC, and QP.

    Visit Website

    NMDP BioTherapies is the only cell and gene therapy solutions provider with customizable services to support the end-to-end cell therapy supply chain. Backed by the industry-leading experience of NMDP℠ and a research partnership with the CIBMTR® (Center for International Blood and Marrow Transplant Research®), the organization designs solutions that advance the development of cell and gene therapies across the globe.

    NMDP BioTherapies is dedicated to accelerating patient access to life-saving cell and gene therapies by providing high-quality cellular source material from the NMDP Registry℠, the world's most diverse registry of more than 7 million potential blood stem cell donors. Through established relationships with apheresis, marrow collection, and transplant centers worldwide, the organization develops, onboards, trains, and manages expansive collection networks to advance cell therapies.

    NMDP BioTherapies uses a proven infrastructure consisting of regulatory compliance and managed logistics experts and cell therapy supply chain case managers to successfully transport and deliver regulatory-compliant life-saving therapies across the globe. Through the CIBMTR, NMDP extends services beyond the cell therapy supply chain to include long-term follow-up tracking for FDA-approved CAR-T therapies.

    Visit Website

    NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations.

    NOF's lipid nanoparticle platform for nucleic acid delivery composed of COASOMEⓇ SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity.

    The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF LNP platform is becoming adopted in clinical planning by NOF collaborators.

    NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's lipid nanoparticle platform for nucleic acid delivery composed of COASOMEⓇ SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity.

    The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF LNP platform is becoming adopted in clinical planning by NOF collaborators.

    Visit Website

    OrganaBio is a robust and reliable biotech solutions provider for cell therapy and immunotherapy developers.

    OrganaBio has opened doors to a new Contract Technology Development and Manufacturing Organization (CTDMO) paradigm that involves a passionate commitment to ethically accelerating the deployment of cell therapies through making accessible critical resources that are essential for therapeutics development.

    Visit Website

    OriGen Biomedical® manufactures industry-preferred products for cell therapy.

    Our products include the CryoStore Freezing Bag, PermaLife Cell Culture Bag, CryoPur DMSO Solutions, and compatible Accessory Sets.

    Visit Website

    Oxford Biomedica (LSE: OXB) is a quality and innovation-led viral vector CDMO with a mission to enable our partners to deliver life changing therapies to patients around the world.

    One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

    The Company collaborates with some of the world's most innovative pharmaceutical, biotech and stealth companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. 

    Oxford Biomedica's world-class capabilities span from early-stage development to commercialization. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

    Visit Website

    Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster.

    Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 22,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere.

    Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient.

    With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference.

    Visit Website

    PBL SRL is an Italian SME, leader in the design and production of customized automated lines for pharmaceutical industry.

    Thanks to its experience, PBL represents the ideal partner for developing automated lines for the manufacturing of ATMPs.

    Visit Website

    PeptiGrowth Inc., a joint venture between Mitsubishi Corporation and PeptiDream Inc., is supporting the growth of regenerative medicine and cell therapy industry by offering a series of synthetic peptides that have equivalent functions to growth factors.

    Our peptides are chemically synthesized, completely animal component-free, and can achieve highly consistent quality, excellent scalability, and reasonable cost.

    PeptiGrowth has launched 6 products as of September 2023 – HGF, TGF-β1 inhibitor, BDNF, Noggin, and BMP 4 or 7 selective inhibitor peptides – and is planning to launch more products in iPSC and hematological fields including VEGF, Wnt3a, FGF2, PDGF-AA, and TPO peptides in the next 6 months.

    Visit Website

    phasetwo® offers a full range of storage products that have been re-engineered with a user-centric focus, rather than legacy and outdated designs.

    Our next generation solutions serve the Life Science sectors including Biotech, Cell and Genetic Therapy, Dermatology, Biobanking, In Vitro Fertilization and more. 

    Our advanced cold storage products include Cryogenic Storage Stainless Steel Freezers, Cryogenic Aluminum Freezers, Cryogenic Freezers, Cryogenic Control Rate Freezers, Cryogenic Blast Freezers, and Dry Ice Equipment.

    Visit Website

    Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HPL), offering a complete portfolio of HPL products tailored for various use cases; from standard laboratory research to GMP compliant cell therapies.

    PL BioScience was founded in 2015 as an RWTH Aachen University spin-off. Since then, they have been exploring the broad potential of human platelets with a mission is to enhance advances in cellular research and therapy with one forward-looking Technology: ELAREM™.

    The high growth factor content of HPL combined with its animal-free origin not only supports optimal cell growth, but also enables it’s use in various applications.

    From academic research, pre-clinical research, to cellular therapy, the high quality GMP compliant standards of ELAREM™ ensures seamless transitions of regenerative medicine breakthroughs – from the lab to patients in need.

    Visit Website

    Proteintech, founded in 2002, is a leading manufacturer of antibodies, proteins and immunoassays. 

    Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering 2/3 of the human proteome. With over 70,000 publications and confirmed specificity, Proteintech offers antibodies and immunoassays across research areas. 

    In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade.  Proteintech sites are ISO13485 and ISO9001-2015 accredited. 

    To learn more about Proteintech, please visit 

    Visit Website

    Preserving Life For Tomorrow™ Protide Pharmaceuticals, Inc. is a fully integrated organization devoted to innovative solutions that support research and development in regenerative medicine, cancer biology, cell bioenergy, cancer immunology, translational medicine, epigenetics, and islet cell transplantation.

     With over 37 years of innovative products and services, and hundreds of clinical trials using our technology, we positively impact science through knowledge.

    Inspired by the scientists, patients, and physicians we support, Protide continues as an entrepreneurial, science driven organization.

    Visit Website

    QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services.

    Since 1995, it has rapidly expanded from a tiny bioanalysis shop to a full-service CRO with 1,200+ employees in the US, Europe, India and Asia.

    Today, it offers expanded pharmaceutical contract R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development.

    Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers.

    For more information, visit or email

    Visit Website

    REPROCELL's corporate vision is to promote human health by providing cutting-edge research products, services, and partnerships that advance the future of Regenerative Medicine.

    At REPROCELL, we can manufacture custom GMP iPSC or MSCs Master Cell Banks (MCB) compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. The custom and the off-the-shelf iPSC Seed Clones are made with our 4th Generation clinical mRNA reprogramming technology and are available for the Sponsor to evaluate for suitability before the MCB generation step or clinical gene editing.

    For drug discovery, REPROCELL’s pre-clinical contract research organization is an experienced partner uniquely positioned to provide custom assay services using live human tissues or 3D tissue models.

    Our Central Laboratory Services offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, we deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research.

    We can help with all areas of regenerative medicine preclinical development as REPROCELL has expanded through a series of acquisitions over recent years creating a workflow including human tissue acquisition (BioServe®), RNA reprogramming (Stemgent®), 3D technologies (Alvetex®), and drug discovery (Biopta®) to the development of clinical stem.

    Visit Website

    RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies.

    Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity.

    With optimized, scalable processes, Type 2 Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year.

    RoosterBio is driven by clients’ success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

    Visit Website

    Saint-Gobain Life Sciences is an industry-leading provider of material science-based solutions for single-use fluid management, including TPE and silicone tubing, connection and flow control components, bioprocess and cell culture bags, filtration products, sensors, and over-molded technology, all available in customized assemblies that are produced in 20 manufacturing facilities located around the world.

    Visit Website

    Sanguine Biosciences is accelerating personalized medicine by empowering patients with their healthcare data, and facilitating participation in biomedical research.

    Sanguine actively bridges the gap between patients and researchers through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services.

    Visit Website

    As the industry continues to move at an unprecedented speed, we provide Solutions that help immune cell therapy developers and manufacturers accelerate their time to market and lower their COGs.

    Our portfolio can help reduce complexity in developing therapies and accelerate timelines with streamlined workflows that translate to positive clinical outcomes, all while reducing the cost of development.

    We empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.

    Visit Website

    Scinus Cell Expansion provides technologies and process development to enable and improve cell therapy and regenerative medicine.

    Our main product is the SCINUS bioreactor NG, which is a closed bioreactor system for the controlled cultivation of cells, supporting R&D as well as GMP processes.

     Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique, volume-expandable, rocking platform that provides an optimally homogenized culture environment with minimal shear stresses.

    Two different single use bioreactor bag can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells), as well as suspension cells (e.g. T-cells, NK cells) to clinically relevant numbers. Both bags can be used with the same Scinus Cell Expansion system configuration.

    For an illustrative animation, please check our website (

    Visit Website

    SCTbio is a cell-based therapy and retroviruses vector CDMO spun out from SOTIO Group in 2021, led by a tight-knit team that has been through every stage of process and product development over the last
    decade, bringing Sotio Biotech’s autologous cell therapies into phase III.

    From its 2,000 sqm facility in Central Europe, SCTbio offers personal attention through long-term manufacturing partnerships, offering strategic development and regulatory guidance alongside full services covering GMP production, testing and logistics of advanced therapy medicinal products, including genetically modified and viral vectors.

    SCTbio is supported by PPF Group.

    Visit Website

    Founded in 1947, SEKISUI CHEMICAL is a chemical manufacturer that provides products worldwide in industries such as housing materials, water/environmental infrastructure, electronics/mobility, and life science.

    Sekisui America Corporation is the market development division of Sekisui Chemical primarily working on expanding our global presence in life science industry including cell culture consumables. 
    We have developed new cell culture consumables such as state-of-art chemically defined scaffold and medium for iPS cell culture. We're looking for collaboration partners such as cell and gene therapy research organizations, pharmaceuticals, CDMOs and device manufacturers.

    Currently, protein-based scaffolds are mainly used for culturing pluripotent stem cells, but these scaffolds lack handling stability due to large product variability, and they also pose the problems of safety against viral contamination and high culturing and storage costs. In order to solve these problems of conventional scaffolds, we have developed and provided scaffolds based on synthetic polymer that can be coated by machine and stored at room temperature, which can establish a safe and stable cell culture work environment and can be adapted to automated culture equipment.

    We are looking for collaboration partners from cell and gene therapy area such as below.

    • Academic organizations which have researched regenerative medicine especially for using iPSC or MSC. 
    • Pharmaceutical companies including startups which have the potential to adapt our scaffold or medium for their pipelines
    • Equipment or automated bioreactor manufacturers which may be potential joint development partner adapting our products

    Visit Website

    Sendum’s Advanced Therapy Visibility Solutions help Life Sciences companies specializing in Advanced Therapies and Biologics to ensure the integrity and visibility of their products at scale.

    Tailored to integrate within existing operations, our platform automates the mapping and governance of both physical and digital risk events throughout the extended value chain.

    Established in 2001 and headquartered in Burnaby, BC, Canada, Sendum's solutions address the unique challenges of ATMPs, offering unparalleled "deep visibility" into the Chain of Identity, Chain of Custody, and Chain of Condition.

    This focus enables our customers to mitigate risks effectively, ensuring product safety and compliance with regulatory standards. Sendum is a trusted partner in over 500 clinical trials globally, enhancing the delivery and reliability of critical therapies.

    Visit Website

    As leading contract service organization for over 40 years, SGS provides best-in-class services to support drug development from molecule to market, helping clients deliver high-quality, safe, and effective medicines to patients.

    With more than 20 GMP facilities worldwide, our global network of scientific experts accelerates drug development using innovative techniques and a consultative approach to development and formulation; as well as comprehensive quality control testing for raw materials, APIs, and finished products; and manufacturing to support phase 1 - 3 clinical trials.

    Visit Website

    SINFONIA TECHNOLOGY, CO., LTD. is a provider of a fully closed and automated cell culturing instrument named CellQualia Intelligent System to realize Quality by Design based cell manufacturing and Cell and Gene Therapy 4.0.

    CellQualia is Sinfonia’s brand name of the products related to regenerative medicine. It is a coined word by combining the word "Cell" with the word "Qualia", which reminds us of quality, so the brand name expresses our commitment to focus on the quality of our cells.

    Our company was founded in 1917 and keeps providing products in 12 business fields, ranging from semiconductor transport equipment to electrical components for space rockets, test equipment, vibration conveyance equipment, small motors, electromagnetic clutches/brakes, and even printers with our unique motion control and energy control technologies.

    Regenerative medicine is new business field to us, but we will strive to develop and provide cutting-edge products and contribute to medical care.

    Visit Website

    Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development.

    All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

    Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

    Visit Website

    The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) looks to complement the current SDO processes for standards development by engaging regenerative medicine stakeholders to ensure that new or revised standards provide the greatest benefits to the field.

    To accomplish this and to keep up with the fast-paced growth of regenerative medicine and advance standards, SCB engages, coordinates, and educates the regenerative medicine community.

    Visit Website

    The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research.

    From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects and 30 clinical trials.

    Since its inception, over 25 biotech companies have been catalyzed or enhanced and more than 6,400 highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–2025 period.

    Visit Website

    Stem Genomics is a biotech company specialized in the development of innovative testing solutions for research scientists working on human stem cells. Whether you work on Pluripotent Stem Cells (PSCs), Mesenchymal Stromal Cells (MSCs) or other types of human stem cells, we can perform various categories of tests and analyses suited to your specific needs.

    Our flagship testing solution, digital PCR-based assay iCS-digital™ PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. We can also perform the following tests for you: G-Banding karyotyping, mycoplasma detection, STR (Short Tandem Repeat), aneuploidy detection, Next Generation Sequencing or design customized assays to meet your requirements.

    All our tests will take into account the constraints related to the cell type you work with. With all the assays we perform, you will receive clear, straightforward reports to make it easier to understand the analysis and to support your decision-making process.

    Visit Website

    STEMSOFT Software offers a fully electronic solution designed to document all phases of patient care and product manufacturing. Our software solutions allow you to save time, comply with quality and accreditation requirements, and easily access a complete dataset for analysis.

    The latest ICCBBA specified ISBT-128 Cellular Therapy collection label templates are provided via our STEMSOFT LAB product, and our batch record software is configurable and workflow driven, allowing you to focus on producing your products.

    Visit Website

    Symcel provides a novel instrument for real-time biological activity measurements using a powerful technique called isothermal microcalorimetry. Particularly useful and suited for sterility testing in Cell and Gene Therapy products and processes.

    Our solution, the calScreener™, delivers a phenotypic, metabolic readout in real-time. By directly measuring the heat produced as a result of metabolic processes in the sample, you get an energy output measured in μW, that provides faster insights, not previously possible with traditional methods. Measurements are sample independent meaning you can use finished product samples or process samples. Simply place your sample in the calScreener™ and let it do the rest. You can measure the kinetics of metabolism, in real-time and without the need for additional reagents.

    Visit Website

    For over 50 years, Takara Bio has been committed to helping scientists break new ground with our innovative technologies.

    Our extensive portfolio of reagents, instruments, and services support advancements in the life sciences, including frontline diagnostics and clinical applications. 

    Our products support applications including stem cell research; NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi and gene editing; and plant and food research.

    Visit Website

    Over 45 years of experience have made Technoflex an innovative firm, as well as a European leader in the design and manufacture of flexible bags and connectors for the pharmaceutical industry.

    Our cutting-edge technology and internal R&D resources enable us to provide customized, reliable and easy-to-use solutions. Our proficiency in the pharmaceutical primary packaging of injectable drugs and cell culture, allows us to produce innovative containers matching strong acceptance quality limit (AQL) level within our ISO 7 (Class 10000) clean room.

    Technoflex has also developed a high capacity working with all kinds of flexible films, which may be subject to high thermal amplitudes and permeability. As for cellular therapy, SafeCell® and Cryocell® are state-of-the-art bags delivering high value in the areas of: ex-vivo cell culture, development of cell therapy treatment, blood derivatives, cryopreservation of cord blood and stem cells, and organ preservation.

    SafeCell®, our range of FEP bags, developed with a specific leak-proof design, offers optimal traceability. Recently Technoflex has released a new primary packaging, Dual-Mix®, for the reconstitution of unstable molecules.

    Technoflex’s flexible containers are compliant with the US & EU pharmacopoeias (EP 3.1.3 & EP 3.1.6, 21CFR 77.18.10, USP class V, FDA DMF #19057, DMF #032647 and Canada DMF #2007-070).

    Visit Website

    Trince offers a novel intracellular delivery (transfection) technology for the life sciences/biotech field.

    The LumiPore platform is based on the interaction between pulsed laser light and photothermal nanomaterial. When irradiating the proprietary nanoparticles with laser light, highly localized light-induced thermal and mechanical forces are generated. When the nanoparticles are in close contact with the cell membrane, these light-induced forces can form transient pores in the membrane through which external effector molecules can enter the cell.

    This ‘photoporation’ technology was developed as a next-generation intracellular delivery platform for efficient, flexible gentle, and safe delivery of a wide variety of effector molecules in a broad range of primary and hard-to-transfect cells, maintaining high therapeutic quality.

    The technology can deliver a large variety of payloads in many different hard-to-transfect cell types, including suspension and adherent cells (directly in a standard lab recipient) and even living tissue slices.

    Visit Website

    A world-class CRO & CDMO partner for biologics development.

    Visit Website

    Here’s the deal. We’re all about helping cell and gene therapy researchers break free from tools that just don’t cut it.

    Unleashing problem-tackling solutions that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.

    Visit Website

    Vector BioMed provides rapid access to high-titer Lentiviral vectors. We have extensive experience in algorithm optimized lentiviral vector design, research grade, pre-clinical grade and GMP-grade Lentiviral vector manufacturing, testing and support services.

    We saw the need for high-quality Lentiviral vectors for rapid clinical translation, so we built a company that accelerates our partners path to the clinic, and ultimately commercialization.

    We also enable our partners to locally manufacture affordable CAR-T cell therapies by providing high-quality materials and training for their clinical development and regulatory approval.

    We are determined to provide our partners with the best possible service so they can achieve their goals and make their Lentiviral vector-based medicines a clinical reality.

    Visit Website

    VectorBuilder is a global leader in gene delivery technologies.

    As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside

    Visit Website

    Versiti supports biopharma and cell therapy companies through biomaterial provision, as well as central laboratory, clinical trial logistics and IRB services.

    Biomaterial Provision: We provide a reliable supply of raw starting biomaterials through an IRB-approved collection process. Our Leukopak products are available for Research Use Only (RUO) and Clinical Grade (compliant with FDA 21 CFR 1271 – GMP suitable) applications.

    We navigate contributor collections to provide a high-quality, well-characterized Leukopak product via our comprehensive service model. Additional blood components such as buffy coats, red blood cells, and plasma are available through our healthy donor bank.

    Clinical Trial Services: We are pleased to offer project management and trial support, custom assay development and validation, central laboratory services and specialty testing, data management and biostorage solutions, quality and regulatory services and custom kit supply and biologistics.

    IRB Services: Salus IRB and Pearl IRB are AAHRPP-accredited, independent review boards that are committed to upholding the highest standards in human research protection while providing quick, consultative customer service and expertise. Offerings include review board meetings 3x/week; accelerated phase 1, national and international, central, and local review capabilities; IRB-exempt determinations; minimal-risk research; institutional outsourcing; and investigator-initiated/sponsored research.

    Learn more at:

    Visit Website

    Driven by innovation and built around one of the most prolific academic viral vector manufacturing teams, ViroCell Biologics is focused on supporting therapeutic developers using lentiviral and retroviral vectors from the earliest stages of vector design & optimization through preclinical supply to clinical GMP manufacturing.

    We are committed to helping companies improve safety and solve the next challenges in cell and gene therapy through our innovation research programs. Our team leverages its deep track record in vector design and innovation to help clients de-risk their products with data-driven vector selection to move to the clinic with confidence.

    ViroCell’s platform processes and established capabilities enable clients to accelerate their novel therapies into GMP manufacturing and release so that they can reach the clinic quickly and affordably. ViroCell’s MHRA-licensed facility is in London, from which we export globally. Our clients come from all over the world and range from academic investigators to large pharma.  

    Visit Website

    As a leading CRO specializing in virus and prion safety testing, ViruSure offers comprehensive biosafety solutions for CGT products and biopharmaceuticals.

    Our GLP/GMP-certified in vitro and in vivo facilities ensure the highest quality standards, baked by a proven track record of reports accepted by regulatory authorities worldwide.

    We provide expert guidance tailored to your specific CGT product, spanning a diverse range, including cell therapy, CAR T-cells, iPSCs, gene editing, exosomes, and tissue engineering.

    Our service portfolio includes: SAFETY TESTING - Cell and virus characterization - In vitro/in vivo adventitious testing - RCL and RCA testing MOLECULAR BIOLOGY - Rapid mycoplasma testing by qPCR - qPCR for pathogenic viruses (human, bovine, porcine and more) - Viral titre determination by dPCR - Genetic stability by dPCR - Sanger sequencing NEXT GENERATION SEQUENCING - NGS for adventitious testing (virus, sterility, mycoplasma) - NGS for genetic characterization (sequence identity confirmation) IN VIVO TESTING - Tumorigenicity & oncogenicity studies - In vivo biodistribution studies tailored to CGT OTHER SERVICES - Long-term storage facility - Virus/prion clearance studies - TEM - Cell and virus banking.

    Visit Website

    VitaCyte manufactures, supplies, and directly sells defined collagenase & neutral protease enzymes for cell isolation or recovery of cells after culture. VitaCyte offers three categories of purified-defined collagenase products: lower-cost natural PD Collagenases and higher-cost natural and recombinant collagenases. These GMP Grade products are consistently manufactured (i.e., minimal lot-to-lot variability) and are > 95% pure. The recombinant collagenase is animal-origin-free.

    VitaCyte also offers four purified GMP Grade neutral protease products: AM Protease, BP Protease (Dispase equivalent enzyme), Clostripain, and Thermolysin. AM Protease is used primarily for human amniotic cell isolation, whereas the other enzymes are used in a broad range of applications. All these enzymes are animal-origin-free except clostripain.

    VitaCyte’s rigorous characterization of collagenase enzymes led to the development of four different reversed-engineered, purified-defined collagenase-protease mixtures used to isolate specific cell populations. These purified defined products replaced the inconsistent traditional collagenase products that required lot testing before purchase.

    VitaCyte provides a “reverse-engineering” service by first analyzing the client’s collagenase and protease enzymes, then reviewing these results with the client and proposing the substitution of these enzymes with a mixture of VitaCyte’s purified-defined enzymes that becomes a second source of enzyme. The benefits of this approach are that the client knows the biochemical properties of the enzymes used in their manufacturing process, can share these results with regulatory authorities, and has access to a second source of enzymes.

    Visit Website

    Xcell Biosciences is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing.

    Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. 

    This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing.

    Visit Website

    X-Therma is headquartered in the San Francisco Bay Area, with a research center in Berkeley, cGMP manufacturing centers in Hercules and a product development center in Austria.

    X-Therma pioneers a ground-breaking cold chain platform via a proprietary bio-preservation technology, to bring living vaccines, cell & gene therapies, engineered tissues, organs and IVF to patients off-the-shelf, unleashing the grand potential of all regenerative medicines. XT-Thrive® successfully replaces toxic DMSO solutions in cryopreservation and solves legacy bottlenecks in cell & gene therapy scale-up of cGMP production. XT-Thrive is now being utilized in partnerships with leading CGT innovators.

    The critical extension of transplantation window by the XT-ViVo® and TimeSeal® Breakthrough saves the mass of organs not utilized today (80%) and enables usage of xeno-/engineered-organs. X-Therma is on its way to be the paradigm shift that makes worldwide organ sharing possible and diminishes organ waiting lists across the globe. X-Therma has been a selected Industrial User at the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company closed an oversubscribed Series A of $13M and is actively preparing for Series B fundraising.

    The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status.

    X-Therma has active pilot projects with global clients, which include top cell and gene therapy companies, CDMOs/CMOs applying XT-Thrive® for cryopreservation to meet their demand for large scale cell manufacturing. Contact us to inquire about XT-Thrive® or partnership opportunities.

    Visit Website

    Xcell Therapeutics has developed a chemically defined media which do not contain any animal or plant-derived components.

    We have launched a variety of cell culture media for hMSC expansion and exosome isolation. Besides that, we will release the NK, T cell culture media in the near future.

    Visit Website


    AseBio, the Spanish Bioindustry Association, brings together and represents the interests of companies, associations, foundations, universities and technology and research centres that work in the field of biotechnology in Spain.

    AseBio collaborates closely with regional, national and European governments, as well as with social organisations that are committed to science and the use of biotechnology to improve people’s lives and promote environmental sustainability, economic development and high value-added employment.

    Over the past 25 years, we have been working to bring about positive political and economic changes that foster and drive development of the Spanish biotechnology sector. We are committed to the use of biotechnology to improve quality of life and promote environmental sustainability, economic development and qualified jobs.

    AseBio is a community committed to science and innovation as a driving force for sustainable economic development and social wellbeing. We’ve created an inclusive ecosystem, open to all, with the aim of finding innovative solutions to the social and generational challenges we are facing.

    Visit Website

    BioCanRx is Canada’s Immunotherapy Network.

    Our vision is to turn all cancers into curable diseases. We are a network of scientists, clinicians, cancer stakeholders, academic institutions, NGOs and industry partners working together to accelerate the development of leading-edge immune oncology therapies for the benefit of patients.

    As a leader in the translation, manufacture and adoption of cancer immunotherapies, we invest in translating world-class technologies from the research lab into clinical trials.

    BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities. We train and develop the talent needed for a thriving Canadian health biotechnology sector.

    BioCanRx receives funding from the Government of Canada and support from industry, the provinces and charities.

    Visit Website

    Gene Therapy Canada is a grass roots organization bringing together Canadian scientists, industry leaders, service providers and clinicians actively working and innovating in Gene Therapy. Our mission is to advance Gene Therapy in Canada and globally through building a collaborative ecosystem and strong network to facilitate knowledge and skill exchange.

    Visit LinkedIn Group

    The Japanese Society of Regenerative Medicine (JSRM) is involved in a wide variety of research in the natural sciences field such as basic medicine/dentistry, clinical medicine/dentistry, tissue engineering, and cell biology, as well as fields in the humanities and in sociology such as bioethics, regulatory science, law, and medical economics. Its participating members come from various domains of academia, industry, and government.

    Visit Website

    Founded in 1996, The Korean Society of Blood and Marrow Transplantation (KSBMT) was previously called the Korea Research Council of Bone Marrow Transplantation. The first scientific meeting of the Council was held on February 6, 1991, with the participation of 16 members. The Council held roundtable meetings every month to present and exchange clinical experience among members, which contributed to the development of bone marrow transplantation in Korea. The Council also played a leading role in ensuring that bone marrow transplantation was covered by the national health insurance starting from October, 1992.

    The necessity of founding a society was raised to increase the number of hospitals that performed bone marrow transplantation, increase the number of members, and create advocacy for the new discipline of stem cell transplantation. In this setting, around 130 members gathered together in spring of 1996 to establish the KSBMT.

    Visit Website

    The Stem Cell Network (SCN) is a Canadian not-for-profit that supports three main objectives: stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and supporting the knowledge mobilization and transfer of stem cell and regenerative medicine research.

    From the lab to the clinic, our goal is to power science that will benefit Canadians and all people. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects and 30 clinical trials. Since its inception, over 25 biotech companies have been catalyzed or enhanced and more than 6,400 highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–2025 period.

    Visit Website